- The authors of this systematic review of mobile apps for cardiovascular disease (CVD) management find some benefit of the apps for self-management of hypertension and ischemic heart disease (IHD).
- Complications and QoL could be improved with use of these apps, they say.
Why this matters
- Hypertension and IHD both require close management, even as patients experience lengthy periods without symptoms.
- 12 of 17 included articles were rated as “acceptable,” 1 was fair, and 4 were poor quality.
- Mean participant age was 47.5-73.8 years.
- Interventions lasted 3 weeks to 12 months.
- App-based interventions involved monitoring, education, and reminders.
- BP was reduced in association with app use in 5 of 7 included studies of hypertension.
- 5 articles measuring medication adherence found improvements with app-based medication reminders, especially with IHD.
- BMI was reduced in 2 of 3 studies of app-based intervention for IHD.
- QoL was improved in 3 IHD-related studies.
- 2 randomized controlled trials found no benefit of apps for smoking cessation in IHD.
- Effects of the apps were inconsistent, depending on both app- and user-related factors.
- Effects seemed to diminish with time.
- Systematic review that included MEDLINE, EMBASE, and CINAHL searches plus 3 Korean databases.
- Funding: None disclosed.
- Some studies were low quality.